Nabriva Therapeutics plc Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Nabriva Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2017 to Q1 2023.
  • Nabriva Therapeutics plc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was -$3K, a 91.7% increase year-over-year.
  • Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$263K, a 225% decline from 2021.
  • Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$81K, a 70.4% increase from 2020.
  • Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$274K, a 183% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$3K +$33K +91.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q1 2022 -$36K +$84K +70% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q1 2021 -$120K -$100K -500% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 -$20K +$22K +52.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$42K +$118K +73.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$160K -$10.1M -102% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $9.98M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.